Reporting owner · CIK 0001804831

Bonnell Brian Michael

SEC Form 4 history across 1 companies, 5 transactions and 2 filings.

CFOChief Financial OfficerICU MEDICAL INC DE
Open-market transaction mix0% buys0 buys · 5 sales

Available history · Aug 31, 2026 – Sep 01, 2026

Filings2Form 4 records
Buying$00 purchases
Selling$2.7M5 sales
Net value−$2.7MBuys minus sells · disclosed values

Latest insider transactions

Form 4 filings from available history.
Bonnell Brian Michael transactions · 20 per page
CompanyInsiderActivityDisclosed valueFiled (ET)
ICUIICU MEDICAL INC DE
Bonnell Brian MichaelCFOS · sale10b5-1 detectedSEC filing ↗-$1.11MView disclosure →
ICUIICU MEDICAL INC DE
Bonnell Brian MichaelCFOS · sale10b5-1 detectedSEC filing ↗-$193kView disclosure →
ICUIICU MEDICAL INC DE
Bonnell Brian MichaelCFOS · sale10b5-1 detectedSEC filing ↗-$792kView disclosure →
ICUIICU MEDICAL INC DE
Bonnell Brian MichaelCFOS · sale10b5-1 detectedSEC filing ↗-$329kView disclosure →
ICUIICU MEDICAL INC DE
Bonnell Brian MichaelCFOS · sale10b5-1 detectedSEC filing ↗-$292kView disclosure →

Latest Form 4 facts

Quick context from source filings

Latest open-market transaction

sale at ICU MEDICAL INC DE on Sep 01, 2026 valued at $1,116,675.

Review SEC filing
Latest buy

No open-market insider purchase is available.

Latest sale

sale at ICU MEDICAL INC DE on Sep 01, 2026 valued at $1,116,675.

Review SEC filing

Monthly open-market activity

Last 2 reported months · purchases and sales

View exact monthly values
Monthly open-market source values
MonthPurchasesSalesBuy valueSale valueNet value
Aug 202604$0.00$1,608,143.29-$1,608,143.29
Sep 202601$0.00$1,116,675.00-$1,116,675.00

Net value is disclosed purchases minus sales, not profit. A dash means the value is unavailable.

Ownership and transaction size

Ownership and ticket size

Average P/S size$545K
Median P/S size$329.4K
Direct5
Indirect0
Sep 01, 2026sale

Filing-only signals

Deterministic matches in this insider's history

Associated companies

Companies in the disclosed reporting history

Open-market buy performance

90-day forward return on this insider's open-market purchases

90d forward
No open-market purchases in available history

A 90-day purchase return requires an open-market buy. No eligible purchases are recorded in this history.

Disclosed ownership

How reported shareholdings evolved

Non-derivative shares held after reported transactions—not stock prices or a complete portfolio.

5 observations · Aug 31, 2026 – Sep 1, 2026. Window ends at the latest available report, not today.

Selected observation · Sep 1, 202656,062 shares reported
Inspect transaction
View exact observations and source transactions
Transaction dateShares held afterFiledSource
Aug 31, 202670,038Aug 31, 2026View transaction
Aug 31, 202668,124Aug 31, 2026View transaction
Aug 31, 202663,556Aug 31, 2026View transaction
Aug 31, 202662,443Aug 31, 2026View transaction
Sep 1, 202656,062Sep 1, 2026View transaction

Securities and direct/indirect ownership contexts are kept separate and never summed. Joint filings may associate the same disclosed row with multiple owners. Unknown values are omitted, not treated as zero. Lines connect observations for readability; they do not establish holdings between filings, cost basis, or current ownership. Amendments and stock splits require reviewing the source.

Bonnell Brian Michael Insider Activity FAQ

SEC Form 4 context

Who is Bonnell Brian Michael?

Bonnell Brian Michael is a reporting owner in SEC Form 4 filings with reporting owner CIK 0001804831.

Which companies has Bonnell Brian Michael reported transactions for?

ICU MEDICAL INC DE

When was Bonnell Brian Michael's latest insider buy?

No open-market insider purchase is available for this period.

When was Bonnell Brian Michael's latest insider sale?

sale at ICU MEDICAL INC DE on Sep 01, 2026 valued at $1,116,675.

Where can I see the original SEC filings?

Each transaction row links directly to the source SEC filing so the reported Form 4 details can be reviewed.

Are performance metrics included?

The profile shows average and median 90-day stock returns after open-market purchases when price coverage is available. These are unadjusted stock returns, not realized trading gains. Win rates, benchmark-adjusted returns and conviction scores are not calculated.